To our Valued Customers,
Champions of Women
Materna Medical is proud to be a female-led company forging a new path for women who are seeking to protect and restore their pelvic health. Overcoming painful vaginal tightness (vaginismus) is an experience that is both deeply personal and intimate, and one that shouldn’t be taboo or isolating. Destigmatizing this journey is at the very heart of our company.
Trusted Relief
Amplifying the educational conversation around this condition has never been more important, since the American College of Obstetricians and Gynecologists estimates that up to 17%1 of women in the United States have vaginismus due to menopause, pelvic pain, post-partum injuries, and more. We believe that women deserve access to treatment options that are cleared by the FDA’s rigorous review processes.
Designed for you
Over the last few years, we’ve been able to impact the lives of thousands of women who are seeking support for their pelvic health. Today, we are thrilled to introduce the next phase of Milli as the first and only FDA cleared over-the-counter vaginal dilator. What makes Milli unique is that unlike static dilators that may have intimidating jumps in sizing, Milli gradually expands within the vagina millimeter by millimeter, ensuring you’re always in control of your pace and progress.
By your side
This is a landmark achievement in women’s health. With this OTC clearance, we have shown that people can self-diagnose vaginismus with the right support.
I am extremely proud of the work Materna Medical has put into leading a pelvic health revolution, and we are honored to support the millions of women impacted by these conditions every day. You are not alone – Milli can help.
Sincerely,
Tracy MacNeal
CEO of Materna Medical
1 ACOG Committee on Practice Bulletins—Gynecology. Female Sexual Dysfunction: ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists, Number 213. Obstet Gynecol. 2019 Jul;134(1)
About Materna Medical
Materna Medical is a novel OBGYN platform company defining a $25B market with core technologies addressing unmet needs in women’s pelvic health. With headquarters in Mountain View, California, Materna pulls from the top minds in MedTech to truly transform the standard of care in OBGYN. With a diverse team of engineers, scientists, researchers, and commercial leaders, Materna Medical’s mission is to empower women to protect their pelvic health.
Our first product, Milli™, is a vaginal dilator to support patients suffering from vaginismus and related painful sex. In 2019, the Milli device launched as a wellness trainer and, in 2023, received FDA clearance to sell over the counter, enabling streamlined access to people suffering from vaginismus. Milli outcomes have been studied in a post-market prospective virtual study named POMPOM.
Materna’s second product, Ellora™, is an investigational device used during labor and is intended to reduce pelvic floor muscle injury during vaginal delivery in first-time moms. This product is being studied in the EASE trial, a large, randomized controlled trial in 20 top US hospitals. Materna aims to transform the standard of care in labor and delivery by protecting pelvic floor health for moms.